The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial
To access this article, please choose from the options below
S.K. has nothing to disclose. S.H.K. has nothing to disclose. G.K. has nothing to disclose.
PII: S0015-0282(09)03860-6
doi:10.1016/j.fertnstert.2009.10.004
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

